Lack of cable pili expression by cblA-containing Burkholderia cepacia complex.

The Burkholderia cepacia complex consists of several closely related bacterial species (or genomovars) which although generally not pathogenic for healthy individuals, contribute significantly to morbidity and mortality among persons with cystic fibrosis (CF). Certain B. cepacia complex strains are more frequently recovered from CF sputum cultures than are others, and these typically reside in genomovar III. The ET12 clone is a genomovar III strain that predominates among CF patients in Canada and the United Kingdom and is characterized by distinctive cblA-encoded pili that have a cable-like morphology. In a previous survey of B. cepacia complex isolates recovered from 606 CF patients in the US, a single genomovar III ET12 isolate (isolate AU0007) was identified; several cblA-containing genomovar I isolates, however, were also detected. In the study reported here, analysis by PFGE revealed several distinct strain types among these genomovar I isolates, and sequence analysis of their cblA genes demonstrated 87.8-88.4% identity to the ET12 cblA sequence. Southern analysis indicated that the cblA variant from each genomovar I isolate resides on a 4 kbp EcoRI fragment, in contrast to ET12 isolates, in which cblA localizes to a 5 kbp EcoRI fragment. Western blot assay indicated expression of the 16 kDa major pilin subunit by ET12 isolates, including AU0007, but neither whole-cell nor surface-protein extracts of the genomovar I reacted. Electron microscopy revealed the complete absence of pili expression by the genomovar I isolates. In contrast to typical ET12 isolates, AU0007 appeared to be hyperpiliated with rigid pili that lacked the cable morphology and did not bind cytokeratin 13, which has been previously identified as the epithelial cell receptor for the ET12 cable-pili-associated adhesin.

[1]  R. Goldstein,et al.  Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers , 1995, Journal of bacteriology.

[2]  J. Lipuma,et al.  BURKHOLDERIA CEPACIA: Management Issues and New Insights , 1998 .

[3]  M. Kaufmann,et al.  Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. , 1996, Journal of medical microbiology.

[4]  M. Dodd,et al.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis , 1993, The Lancet.

[5]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[6]  J. Lipuma,et al.  Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. , 2001, American journal of respiratory and critical care medicine.

[7]  M. Whiteford,et al.  Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. , 1995, Thorax.

[8]  M. Riley,et al.  The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain , 1995, Nature Medicine.

[9]  H. Denk,et al.  Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. , 1981, Journal of molecular biology.

[10]  S. Tyler,et al.  Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping , 1994, Journal of clinical microbiology.

[11]  R. Coutts,et al.  Incidence of the cblA major subunit pilin gene amongst Burkholderia species. , 2001, FEMS microbiology letters.

[12]  Tom Coenye,et al.  Taxonomy and Identification of the Burkholderia cepacia Complex , 2001, Journal of Clinical Microbiology.

[13]  J. Parke,et al.  Diversity of the Burkholderia cepacia complex and implications for risk assessment of biological control strains. , 2001, Annual review of phytopathology.

[14]  D. Simpson,et al.  Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis , 1997, Journal of clinical microbiology.

[15]  D. Auble,et al.  Promoter recognition by Escherichia coli RNA polymerase. Influence of DNA structure in the spacer separating the -10 and -35 regions. , 1988, Journal of molecular biology.

[16]  F. K. Graaf,et al.  Organization and expression of genes involved in the biosynthesis of K99 fimbriae , 1984, Infection and immunity.

[17]  P. Vandamme,et al.  Development of rRNA-Based PCR Assays for Identification of Burkholderia cepacia Complex Isolates Recovered from Cystic Fibrosis Patients , 1999, Journal of Clinical Microbiology.

[18]  P. Vandamme,et al.  DNA-Based Diagnostic Approaches for Identification of Burkholderia cepacia Complex, Burkholderia vietnamiensis, Burkholderia multivorans,Burkholderia stabilis, and Burkholderia cepacia Genomovars I and III , 2000, Journal of Clinical Microbiology.

[19]  F. Sylvester,et al.  Cable-Piliated Burkholderia cepaciaBinds to Cytokeratin 13 of Epithelial Cells , 2000, Infection and Immunity.

[20]  M. Corey,et al.  Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada , 2002, Emerging infectious diseases.

[21]  L. Shimkets,et al.  Genetic Structure of a Lotic Population ofBurkholderia , 1995 .

[22]  P. Vandamme,et al.  Diagnostically and Experimentally Useful Panel of Strains from the Burkholderia cepacia Complex , 2000, Journal of Clinical Microbiology.

[23]  Cameron Ackerley,et al.  Interaction of cblA/adhesin‐positive Burkholderia cepacia with squamous epithelium , 2002, Cellular microbiology.

[24]  A. Cravioto,et al.  Hemagglutination activity and colonization factor antigens I and II in enterotoxigenic and non-enterotoxigenic strains of Escherichia coli isolated from humans , 1982, Infection and immunity.

[25]  U. Sajjan,et al.  Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. , 2000, Journal of medical microbiology.

[26]  D. Auble,et al.  Promoter recognition by Escherichia coli RNA polymerase. Effects of substitutions in the spacer DNA separating the -10 and -35 regions. , 1986, The Journal of biological chemistry.

[27]  J. Lipuma,et al.  Commercial use of Burkholderia cepacia. , 1999, Emerging infectious diseases.

[28]  J. Lipuma,et al.  Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis. , 2001, The Journal of pediatrics.

[29]  J. Forstner,et al.  Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis , 1992, Infection and immunity.

[30]  M. Kaufmann,et al.  Distribution of Genes Encoding Putative Transmissibility Factors among Epidemic and Nonepidemic Strains ofBurkholderia cepacia from Cystic Fibrosis Patients in the United Kingdom , 2000, Journal of Clinical Microbiology.